Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.31 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29270632 | 0.85 | NPC1 (0.44) | GRM2BACE1BACE2MAPT | |
| SCHEMBL26961398 | 0.85 | RAB9A (0.34) | HDAC6HDAC1BACE1BACE2TERT | |
| SCHEMBL29270464 | 0.85 | GRM2 (0.33) | GRM2BACE1BACE2TERTGAA | |
| SCHEMBL29270587 | 0.84 | HPGD (0.40) | GRM2BACE1BACE2MAPT | |
| SCHEMBL29270473 | 0.84 | KMT2A (0.42) | GRM2BACE1BACE2MAPT | |
| SCHEMBL29270768 | 0.82 | ADCY8 (0.35) | GRM2MAPT | |
| SCHEMBL29270682 | 0.82 | KDM4E (0.39) | GRM2BACE1BACE2MAPT | |
| SCHEMBL29270572 | 0.81 | SPHK2 (0.34) | GRM2BACE1BACE2 | |
| SCHEMBL29270543 | 0.81 | GRM2 (0.33) | GRM2BACE1BACE2 | |
| SCHEMBL29270680 | 0.81 | BRD4 (0.35) | GRM2BACE1BACE2TERTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116964048-A | Bicyclic tetrahydroazepine derivatives for the treatment of cancer | 豪夫迈·罗氏有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116964048-A | Bicyclic tetrahydroazepine derivatives for the treatment of cancer | 豪夫迈·罗氏有限公司 | 2023-10-27 | — | — | CN | disclosed |